diminazene has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gachie, BM; Kagira, JM; Karanja, SM; Maina, NW; Maranga, DN; Ngotho, M; Waema, MW | 1 |
| Afzal, A; Agarwal, D; Bradford, C; Bruce, E; Cardounel, AJ; Douglas, JY; Ferreira, AJ; Fraga-Silva, RA; Francis, J; Gjymishka, A; Grant, MB; Gupta, D; Jarajapu, YP; Jun, JY; Katovich, MJ; Kearns, P; Kennedy, WR; Mocco, J; Mubarak, KK; Patel, JM; Qi, Y; Raizada, MK; Rathinasabapathy, A; Rigatto, K; Shenoy, V | 1 |
2 other study(ies) available for diminazene and Disease Exacerbation
| Article | Year |
|---|---|
IgM, lgG and IL-6 profiles in the Trypanosoma brucei brucei monkey model of human African trypanosomiasis.
Topics: Animals; Antigens, Protozoan; Chlorocebus aethiops; Diminazene; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Immunoglobulin M; Interleukin-6; Trypanosoma brucei brucei; Trypanosomiasis, African | 2017 |
Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.
Topics: Animals; Cell Migration Assays; Diminazene; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Hypertension, Pulmonary; Male; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Stem Cells; Trypanocidal Agents | 2013 |